These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38940005)

  • 21. Use of Oral Anticoagulation in a Real-World Population With Device Detected Atrial Fibrillation.
    Kaplan RM; Ziegler PD; Koehler J; Landman S; Sarkar S; Passman RS
    J Am Heart Assoc; 2020 Dec; 9(24):e018378. PubMed ID: 33252286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of atrial fibrillation on early complications and one year-survival after cardioverter defibrillator implantation: results from the German DEVICE registry.
    Köbe J; Wasmer K; Andresen D; Kleemann T; Spitzer SG; Jehle J; Brachmann J; Stellbrink C; Hochadel M; Senges J; Klein HU; Eckardt L
    Int J Cardiol; 2013 Oct; 168(4):4184-90. PubMed ID: 23948108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Implications of Brief Device-Detected Atrial Tachyarrhythmias in a Cardiac Rhythm Management Device Population: Results from the Registry of Atrial Tachycardia and Atrial Fibrillation Episodes.
    Swiryn S; Orlov MV; Benditt DG; DiMarco JP; Lloyd-Jones DM; Karst E; Qu F; Slawsky MT; Turkel M; Waldo AL;
    Circulation; 2016 Oct; 134(16):1130-1140. PubMed ID: 27754946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors and long-term clinical outcomes of newly developed atrial fibrillation in patients with cardiac implantable electronic devices.
    Kim BS; Chun KJ; Hwang JK; Park SJ; Park KM; Kim JS; On YK
    Medicine (Baltimore); 2016 Jul; 95(28):e4181. PubMed ID: 27428213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The natural history of atrial fibrillation in patients with permanent pacemakers: is atrial fibrillation a progressive disease?
    Veasey RA; Sugihara C; Sandhu K; Dhillon G; Freemantle N; Furniss SS; Sulke AN
    J Interv Card Electrophysiol; 2015 Oct; 44(1):23-30. PubMed ID: 26139311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Temporal Association Between Episodes of Atrial Fibrillation and Risk of Ischemic Stroke.
    Singer DE; Ziegler PD; Koehler JL; Sarkar S; Passman RS
    JAMA Cardiol; 2021 Dec; 6(12):1364-1369. PubMed ID: 34586356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of kidney function and atrial fibrillation progression to clinical outcomes in patients with cardiac implantable electronic devices.
    Szummer K; Pundi K; Perino AC; Fan J; Kothari M; Turakhia MP
    Am Heart J; 2021 Nov; 241():6-13. PubMed ID: 34118202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implantable cardiac monitors to detect atrial fibrillation after cryptogenic stroke: a systematic review and economic evaluation.
    Edwards SJ; Wakefield V; Jhita T; Kew K; Cain P; Marceniuk G
    Health Technol Assess; 2020 Jan; 24(5):1-184. PubMed ID: 31944175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Are implantable cardiac monitors the 'gold standard' for atrial fibrillation detection? A prospective randomized trial comparing atrial fibrillation monitoring using implantable cardiac monitors and DDDRP permanent pacemakers in post atrial fibrillation ablation patients.
    Podd SJ; Sugihara C; Furniss SS; Sulke N
    Europace; 2016 Jul; 18(7):1000-5. PubMed ID: 26585596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The increased risk of stroke/transient ischemic attack in women with a cardiac implantable electronic device is not associated with a higher atrial fibrillation burden.
    Boriani G; Lip GYH; Ricci RP; Proclemer A; Landolina M; Lunati M; Padeletti L; Zanotto G; Molon G; Biffi M; Rordorf R; Quartieri F; Gasparini M
    Europace; 2017 Nov; 19(11):1767-1775. PubMed ID: 28031277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of cardiac electronic implantable device in the stratification and management of embolic risk of silent atrial fibrillation: are all atrial fibrillations created equal?
    Di Cori A; Lilli A; Zucchelli G; Zaca V
    Expert Rev Cardiovasc Ther; 2018 Mar; 16(3):175-181. PubMed ID: 29431527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intermittent anticoagulation guided by continuous atrial fibrillation burden monitoring using dual-chamber pacemakers and implantable cardioverter-defibrillators: Results from the Tailored Anticoagulation for Non-Continuous Atrial Fibrillation (TACTIC-AF) pilot study.
    Waks JW; Passman RS; Matos J; Reynolds M; Thosani A; Mela T; Pederson D; Glotzer TV; Zimetbaum P
    Heart Rhythm; 2018 Nov; 15(11):1601-1607. PubMed ID: 29981863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between ventricular pacing and persistent atrial fibrillation in patients indicated to elective pacemaker replacement: Results of the Prefer for Elective Replacement MVP (PreFER MVP) randomized study.
    Ricci RP; Botto GL; Bénézet JM; Nielsen JC; De Roy L; Piot O; Quesada A; Quaglione R; Vaccari D; Mangoni L; Grammatico A; Kozák M;
    Heart Rhythm; 2015 Nov; 12(11):2239-46. PubMed ID: 26142300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of atrial fibrillation ablation on activity minutes in patients with cardiac implantable electronic devices.
    Peigh G; Stanelle E; Ziegler PD; Varberg N; Soderlund D; Passman RS
    Heart Rhythm; 2022 Sep; 19(9):1405-1411. PubMed ID: 35716857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of Atrial Fibrillation After Central Retinal Artery Occlusion.
    Mac Grory B; Landman SR; Ziegler PD; Boisvert CJ; Flood SP; Stretz C; Madsen TE; Reznik ME; Cutting S; Moore EE; Hewitt H; Closser JB; Torres J; Lavin PJ; Furie KL; Xian Y; Feng W; Biousse V; Schrag M; Yaghi S
    Stroke; 2021 Aug; 52(9):2773-2781. PubMed ID: 34092124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atrial fibrillation variability on long-term monitoring of implantable cardiac rhythm management devices.
    Kaplan RM; Ziegler PD; Koehler J; Glotzer TV; Passman RS
    Clin Cardiol; 2017 Nov; 40(11):1044-1048. PubMed ID: 28800149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High Incidence of De Novo and Subclinical Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy and Cardiac Rhythm Management Device.
    Wilke I; Witzel K; Münch J; Pecha S; Blankenberg S; Reichenspurner H; Willems S; Patten M; Aydin A
    J Cardiovasc Electrophysiol; 2016 Jul; 27(7):779-84. PubMed ID: 27060297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ventricular arrhythmias and cardiac arrest in atrial fibrillation patients with pacemakers and implantable cardioverter-defibrillators.
    Fawzy AM; Bisson A; Bentounes SA; Bodin A; Herbert J; Lip GYH; Fauchier L
    Eur J Intern Med; 2023 Sep; 115():70-78. PubMed ID: 37291016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of previously undiagnosed atrial fibrillation in patients with stroke risk factors and usefulness of continuous monitoring in primary stroke prevention.
    Ziegler PD; Glotzer TV; Daoud EG; Singer DE; Ezekowitz MD; Hoyt RH; Koehler JL; Coles J; Wyse DG
    Am J Cardiol; 2012 Nov; 110(9):1309-14. PubMed ID: 22819433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence, indications, risk factors, and survival of patients undergoing cardiac implantable electronic device implantation after open heart surgery.
    Wiggins NB; Chong DT; Houghtaling PL; Hussein AA; Saliba W; Sabik JF; Wazni O; Wilkoff BL; Tarakji KG
    Europace; 2017 Aug; 19(8):1335-1342. PubMed ID: 27738074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.